GANX · Categories · Form 4

GANX - SEC Form 4 insider transactions

Gain Therapeutics Inc. (GANX) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for GANX

• 75d
  SEC Form 4 filed by Mack Gene

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 75d
  SEC Form 4 filed by Fuggetta Gianluca

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 349d
  SEC Form 4 filed by Director Islam Khalid

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 349d
  SEC Form 4 filed by Director Richman Eric I

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 349d
  SEC Form 4 filed by Director Nicaise Claude

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 349d
  SEC Form 4 filed by Director Hasler Hans Peter

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 349d
  SEC Form 4 filed by Director Riley Jeffrey Scott

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 349d
  SEC Form 4 filed by Director Goldstein Dov A Md

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 349d
  SEC Form 4 filed by Director Melincoff Gwen A

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 445d
  SEC Form 4 filed by See Remark Fuggetta Gianluca

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 445d
  SEC Form 4 filed by CEO, President Mack Gene

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 518d
  SEC Form 4 filed by CEO, President Mack Gene

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 713d
  SEC Form 4 filed by Director Islam Khalid

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 713d
  SEC Form 4 filed by Director Hasler Hans Peter

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 713d
  SEC Form 4 filed by Director Melincoff Gwen A

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 713d
  SEC Form 4 filed by Director Nicaise Claude

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 713d
  SEC Form 4 filed by Director Goldstein Dov A Md

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 713d
  SEC Form 4 filed by Director Riley Jeffrey Scott

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 713d
  SEC Form 4 filed by Director Richman Eric I

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 792d
  SEC Form 4 filed by Mack Gene

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 803d
  Alder Matthias covered exercise/tax liability with 6,085 shares and converted options into 20,212 shares, increasing direct ownership by 201% to 21,140 units (SEC Form 4)

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 806d
  SEC Form 4 filed by Fuggetta Gianluca

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 806d
  SEC Form 4 filed by Alder Matthias

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 900d
  Alder Matthias converted options into 637 shares and sold $507 worth of shares (206 units at $2.46), increasing direct ownership by 9% to 5,286 units (SEC Form 4)

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 908d
  Alder Matthias sold $4,550 worth of shares (1,820 units at $2.50), decreasing direct ownership by 27% to 4,855 units (SEC Form 4)

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 980d
  Alder Matthias converted options into 825 shares, increasing direct ownership by 14% to 6,675 units (SEC Form 4)

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 991d
  SEC Form 4: Richman Eric I converted options into 54,900 shares, increasing direct ownership by 25% to 272,629 units

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 991d
  SEC Form 4: Alder Matthias converted options into 2,550 shares, increasing direct ownership by 77% to 5,850 units

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1070d
  SEC Form 4 filed by Alder Matthias

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1079d
  SEC Form 4 filed by Islam Khalid

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1079d
  SEC Form 4 filed by Riley Jeffrey Scott

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1079d
  SEC Form 4 filed by Goldstein Dov A Md

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1079d
  SEC Form 4 filed by Melincoff Gwen A

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1079d
  SEC Form 4 filed by Nicaise Claude

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1079d
  SEC Form 4 filed by Hasler Hans Peter

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1154d
  SEC Form 4 filed by Ballantyne Charles Evan

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1170d
  SEC Form 4 filed by Calabrese Salvatore

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1170d
  SEC Form 4 filed by Fuggetta Gianluca

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1170d
  SEC Form 4 filed by Alder Matthias

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1356d
  SEC Form 4 filed by Richman Eric I

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1356d
  SEC Form 4 filed by Islam Khalid

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1356d
  SEC Form 4 filed by Riley Jeffrey Scott

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1356d
  SEC Form 4 filed by Goldstein Dov A Md

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1356d
  SEC Form 4 filed by Melincoff Gwen A

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1356d
  SEC Form 4 filed by Nicaise Claude

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1356d
  SEC Form 4 filed by Hasler Hans Peter

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1356d
  SEC Form 4 filed by Alder Matthias

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1421d
  SEC Form 4 filed by Calabrese Salvatore

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1421d
  SEC Form 4 filed by Alder Matthias

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1474d
  SEC Form 4: Richman Eric I bought $6,404 worth of shares (2,482 units at $2.58), increasing direct ownership by 1% to 217,729 units

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1478d
  SEC Form 4: Richman Eric I bought $10,840 worth of shares (4,000 units at $2.71) and bought $26,194 worth of shares (9,256 units at $2.83), increasing direct ownership by 7% to 215,247 units

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1478d
  SEC Form 4: Calabrese Salvatore bought $8,100 worth of shares (3,000 units at $2.70) (Amendment)

  4/A - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1482d
  SEC Form 4: Calabrese Salvatore bought $24,300,000 worth of shares (3,000 units at $8,100.00), increasing direct ownership by 59% to 8,100 units

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1510d
  SEC Form 4: Richman Eric I bought $38,716 worth of shares (4,922 units at $7.87), increasing direct ownership by 2% to 216,820 units (Amendment)

  4/A - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1624d
  SEC Form 4 filed by Alder Matthias

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1757d
  SEC Form 4: RICHMAN ERIC I exercised 4,922 units of Common Stock at a strike of $7.87, increasing direct ownership by 2% to 216,820 units

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)

Other GANX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends